MAP2K3 and head and neck cancer: MAP2K3 (MEK3, MKK3) p.Ala84Thr is seen in 24 samples within COSMIC, with the most common (10 samples) from head and neck cancers [25] in respiratory and upper-digestive tract tumours and predicted to be activating.